Table 1 Cancer sites grouped according to prognosis by cancer site measured by good (>66%), medium (33–66%), and poor (<33%) 5-year relative survival in Denmark for cancers diagnosed during 1991–1995
Prognosis 5-year relative survival | Cancer sites |
|---|---|
Good (>66%) | Lip, breast, cervix, corpus, testis, melanoma skin, thyroid, Hodgkin's disease |
Medium (33–66%) | Salivary glands, mouth, colon, rectum, nasal cavity, larynx, uterus, prostate, kidney, bladder, eye, brain and nervous system, endocrine glands, bone, connective tissue, non-Hodgkin's lymphoma, leukaemia, mycosis fungoides |
Poor (<33%) | Tongue, pharynx, oesophagus, stomach, small intestine, liver, gall bladder, pancreas, peritoneum, lung, pleura, ovary, metastases, multiple myeloma |
